韩国老年人镇静催眠药多重用药与跌倒骨折超额风险
结果显示SHD多重用药常见,且跌倒或骨折风险随SHD数量增加呈药物数量依赖性升高。
要点
- SHD使用者中15.28%同时使用两种SHD活性成分,6.49%使用三种及以上。
- 使用两种SHD活性成分者跌倒或骨折诊断的aOR为1.185(95%CI 1.142-1.230)。
- 使用三种及以上SHD活性成分者aOR为1.333(95%CI 1.266-1.404)。
核心结论
- SHD多重用药在韩国老年人群中常见,并与跌倒和骨折风险呈药物数量依赖性增加相关。
主要发现
- SHD使用者中15.28%同时处方两种SHD活性成分,6.49%处方三种及以上;15.63%处方两种SHD类别,4.84%处方三种及以上。
- 与单种SHD活性成分相比,两种SHD活性成分者跌倒或骨折诊断的aOR为1.185(95%CI 1.142-1.230)。
- 三种及以上SHD活性成分者跌倒或骨折诊断的aOR为1.333(95%CI 1.266-1.404)。
- 按药物类别分析时观察到相似趋势。
关键数值与推荐
- SHD多重用药定义包括同时处方两种SHD活性成分(15.28%)、三种及以上(6.49%),以及两种SHD类别(15.63%)、三种及以上(4.84%)。
- 跌倒或骨折风险比较以单种SHD活性成分使用者为参照,两种者aOR 1.185(95%CI 1.142-1.230),三种及以上者aOR 1.333(95%CI 1.266-1.404)。
临床怎么用
- 对老年SHD使用者应关注多重用药情况,评估跌倒和骨折风险,并考虑更安全的处方实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rapid ageing of South Korea has led to a growing use of sedative-hypnotic drugs (SHDs) amongst older people, raising concerns about SHD polypharmacy and the increased risk of falls or fractures. OBJECTIVE: This study examined the prevalence of SHD polypharmacy and its association with falls or fractures amongst older population in South Korea. METHODS: Using the National Health Insurance Service Senior Cohort Database 2.0 (2002-2019), we identified individuals aged 65 and older in 2017. We conducted 1:1 propensity-score matching to compare SHD users (n = 211 451) with non-users. Multivariable logistic regression analyses were conducted, adjusting for osteoporosis, fracture history and comorbidities. RESULTS: Amongst SHD users, 15.28% were prescribed two SHD active pharmaceutical ingredients (APIs) concurrently, and 6.49% received three or more; 15.63% were prescribed two SHD categories, and 4.84% received three or more. The risk of falls or fractures increased with the number of SHDs used. Patients prescribed two SHD APIs had an adjusted odds ratio (aOR) of 1.185 (95% confidence interval [CI]: 1.142-1.230) of having a diagnosis of fall or fracture, and those receiving three or more had an aOR of 1.333 (95% CI: 1.266-1.404), compared to those on a single API. Similar trends were seen when analysing by drug category. CONCLUSIONS: SHD polypharmacy is common amongst Korean older population and is associated with a drug count-dependent increase in the risk of falls and fractures. These findings highlight the need for safer prescribing practices and increased attention to prevent falls or fractures amongst older individuals experiencing SHD polypharmacy.
引用
- Kang M, Jung J, Kang HA, et al. Excess risk of falls and fractures amongst older people with sedative-hypnotic polypharmacy: an analysis of Korean National Health Insurance Senior Cohort Database. Age Ageing. 2025. PMID: 41405941. doi:10.1093/ageing/afaf360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。